Email Alert RSS
Volume 12 Issue 6
Nov.  2021
Turn off MathJax
Article Contents
Abstract
References
Related Articles
LUO Yanwen, ZHU Qingli. Application of Radiomics in Breast Cancer[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(6): 983-988. DOI: 10.12290/xhyxzz.2021-0011
Citation: LUO Yanwen, ZHU Qingli. Application of Radiomics in Breast Cancer[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(6): 983-988. DOI: 10.12290/xhyxzz.2021-0011
shu

Application of Radiomics in Breast Cancer

  • Department of Ultrasound, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China

Funds: 

National Natural Science Foundation of China 81771855

CAMS Innovation Fund for Medical Science 2020-I2M-C&T-B-033

More Information
  • Corresponding author:

    ZHU Qingli  Tel: 86-10-69155494, E-mail: zqlpumch@126.com

  • Received Date: January 04, 2021
  • Accepted Date: February 22, 2021
  • Available Online: November 03, 2021
  • Issue Publish Date: November 29, 2021
    Graphical Abstract
    • Abstract
  • Breast cancer is the most common malignant tumor in Chinese women. Early diagnosis, treatment, and prognosis assessment are important clinical problems to be solved. Radiomics is a non-invasive method for high-throughput extraction and analysis of lesion features of images to provide more potential information of tumors, and guide precise diagnosis and treatment. Recently, it has been widely concerned and studied in breast cancer, covering every stage in the care of patients with breast cancer. In terms of diagnosis, the research has reached the level of maturity and gradually proceeded to the clinical setting. Regarding efficacy evaluation and prognostic prediction, although in its infancy, radiomics shows promising potential. This paper mainly reviews the application of radiomics in the diagnosis, response evaluation, and prognosis prediction of breast cancer.
    • FullText(HTML)
    • References (47)
  • [1]
    Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66: 115-132. DOI: 10.3322/caac.21338
    [2]
    Lambin P, Rios-Velazquez E, Leijenaar R, et al. Radiomics: extracting more information from medical images using advanced feature analysis[J]. Eur J Cancer, 2012, 48: 441-446. DOI: 10.1016/j.ejca.2011.11.036
    [3]
    Gillies RJ, Kinahan PE, Hricak H. Radiomics: Images Are More than Pictures, They Are Data[J]. Radiology, 2016, 278: 563-577. DOI: 10.1148/radiol.2015151169
    [4]
    Hooley RJ, Scoutt LM, Philpotts LE. Breast ultrasonography: state of the art[J]. Radiology, 2013, 268: 642-659. DOI: 10.1148/radiol.13121606
    [5]
    Chitalia RD, Kontos D. Role of texture analysis in breast MRI as a cancer biomarker: A review[J]. J Magn Reson Imaging, 2019, 49: 927-938. DOI: 10.1002/jmri.26556
    [6]
    Jiang Y, Edwards AV, Newstead GM. Artificial Intelli-gence Applied to Breast MRI for Improved Diagnosis[J]. Radiology, 2021, 298: 38-46. DOI: 10.1148/radiol.2020200292
    [7]
    Li J, Sang T, Yu WH, et al. The value of S-Detect for the differential diagnosis of breast masses on ultrasound: a systematic review and pooled meta-analysis[J]. Med Ultrason, 2020, 22: 211-219. DOI: 10.11152/mu-2402
    [8]
    Mao N, Yin P, Wang Q, et al. Added Value of Radiomics on Mammography for Breast Cancer Diagnosis: A Feasibility Study[J]. J Am Coll Radiol, 2019, 16: 485-491. DOI: 10.1016/j.jacr.2018.09.041
    [9]
    McKinney SM, Sieniek M, Godbole V, et al. International evaluation of an AI system for breast cancer screening[J]. Nature, 2020, 577: 89-94. DOI: 10.1038/s41586-019-1799-6
    [10]
    Li H, Mendel KR, Lan L, et al. Digital Mammography in Breast Cancer: Additive Value of Radiomics of Breast Parenchyma[J]. Radiology, 2019, 291: 15-20. DOI: 10.1148/radiol.2019181113
    [11]
    Zhou J, Zhang Y, Chang KT, et al. Diagnosis of Benign and Malignant Breast Lesions on DCE-MRI by Using Radiomics and Deep Learning With Consideration of Peritumor Tissue[J]. J Magn Reson Imaging, 2020, 51: 798-809. DOI: 10.1002/jmri.26981
    [12]
    Lee SE, Han K, Kwak JY, et al. Radiomics of US texture features in differential diagnosis between triple-negative breast cancer and fibroadenoma[J]. Sci Rep, 2018, 8: 13546. DOI: 10.1038/s41598-018-31906-4
    [13]
    Luo WQ, Huang QX, Huang XW, et al. Predicting Breast Cancer in Breast Imaging Reporting and Data System (BI-RADS) Ultrasound Category 4 or 5 Lesions: A Nomogram Combining Radiomics and BI-RADS[J]. Sci Rep, 2019, 9: 11921. DOI: 10.1038/s41598-019-48488-4
    [14]
    Hao W, Gong J, Wang S, et al. Application of MRI Radiomics-Based Machine Learning Model to Improve Contralateral BI-RADS 4 Lesion Assessment[J]. Front Oncol, 2020, 10: 531476. DOI: 10.3389/fonc.2020.531476
    [15]
    Zhang X, Liang M, Yang Z, et al. Deep Learning-Based Radiomics of B-Mode Ultrasonography and Shear-Wave Elastography: Improved Performance in Breast Mass Classifica-tion[J]. Front Oncol, 2020, 10: 1621. DOI: 10.3389/fonc.2020.01621
    [16]
    Wilke LG, McCall LM, Posther KE, et al. Surgical complications associated with sentinel lymph node biopsy: results from a prospective international cooperative group trial[J]. Ann Surg Oncol, 2006, 13: 491-500. DOI: 10.1245/ASO.2006.05.013
    [17]
    Hindié E, Groheux D, Brenot-Rossi I, et al. The sentinel node procedure in breast cancer: nuclear medicine as the starting point[J]. J Nucl Med, 2011, 52: 405-414. DOI: 10.2967/jnumed.110.081711
    [18]
    Cui X, Wang N, Zhao Y, et al. Preoperative Prediction of Axillary Lymph Node Metastasis in Breast Cancer using Radiomics Features of DCE-MRI[J]. Sci Rep, 2019, 9: 2240. DOI: 10.1038/s41598-019-38502-0
    [19]
    Liu J, Sun D, Chen L, et al. Radiomics Analysis of Dynamic Contrast-Enhanced Magnetic Resonance Imaging for the Prediction of Sentinel Lymph Node Metastasis in Breast Cancer[J]. Front Oncol, 2019, 9: 980. DOI: 10.3389/fonc.2019.00980
    [20]
    Schiano C, Franzese M, Pane K, et al. Hybrid (18)F-FDG-PET/MRI Measurement of Standardized Uptake Value Coupled with Yin Yang 1 Signature in Metastatic Breast Cancer. A Preliminary Study[J]. Cancers (Basel), 2019, 11: 1444. DOI: 10.3390/cancers11101444
    [21]
    Yang J, Wang T, Yang L, et al. Preoperative Prediction of Axillary Lymph Node Metastasis in Breast Cancer Using Mammography-Based Radiomics Method[J]. Sci Rep, 2019, 9: 4429. DOI: 10.1038/s41598-019-40831-z
    [22]
    Mao N, Yin P, Li Q, et al. Radiomics nomogram of contrast-enhanced spectral mammography for prediction of axillary lymph node metastasis in breast cancer: a multicenter study[J]. Eur Radiol, 2020, 30: 6732-6739. DOI: 10.1007/s00330-020-07016-z
    [23]
    Giuliano AE, Ballman KV, McCall L, et al. Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial[J]. JAMA, 2017, 318: 918-926. DOI: 10.1001/jama.2017.11470
    [24]
    Zheng X, Yao Z, Huang Y, et al. Deep learning radiomics can predict axillary lymph node status in early-stage breast cancer[J]. Nat Commun, 2020, 11: 1236. DOI: 10.1038/s41467-020-15027-z
    [25]
    Gao Y, Luo Y, Zhao C, et al. Nomogram based on radiomics analysis of primary breast cancer ultrasound images: prediction of axillary lymph node tumor burden in patients[J]. Eur Radiol, 2021, 31: 928-937. DOI: 10.1007/s00330-020-07181-1
    [26]
    Guo X, Liu Z, Sun C, et al. Deep learning radiomics of ultrasonography: Identifying the risk of axillary non-sentinel lymph node involvement in primary breast cancer[J]. EBioMedicine, 2020, 60: 103018. DOI: 10.1016/j.ebiom.2020.103018
    [27]
    Liu C, Ding J, Spuhler K, et al. Preoperative prediction of sentinel lymph node metastasis in breast cancer by radiomic signatures from dynamic contrast-enhanced MRI[J]. J Magn Reson Imaging, 2019, 49: 131-140. DOI: 10.1002/jmri.26224
    [28]
    Goetz MP, Gradishar WJ, Anderson BO, et al. NCCN Guidelines Insights: Breast Cancer, Version 3.2018[J]. J Natl Compr Canc Netw, 2019, 17: 118-126. DOI: 10.6004/jnccn.2019.0009
    [29]
    Li P, Wang X, Xu C, et al. (18)F-FDG PET/CT radiomic predictors of pathologic complete response (pCR) to neoadjuvant chemotherapy in breast cancer patients[J]. Eur J Nucl Med Mol Imaging, 2020, 47: 1116-1126. DOI: 10.1007/s00259-020-04684-3
    [30]
    Chen S, Shu Z, Li Y, et al. Machine Learning-Based Radiomics Nomogram Using Magnetic Resonance Images for Prediction of Neoadjuvant Chemotherapy Efficacy in Breast Cancer Patients[J]. Front Oncol, 2020, 10: 1410. DOI: 10.3389/fonc.2020.01410
    [31]
    Liu Z, Li Z, Qu J, et al. Radiomics of Multiparametric MRI for Pretreatment Prediction of Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer: A Multicenter Study[J]. Clin Cancer Res, 2019, 25: 3538-3547. DOI: 10.1158/1078-0432.CCR-18-3190
    [32]
    Antunovic L, De Sanctis R, Cozzi L, et al. PET/CT radiomics in breast cancer: promising tool for prediction of pathological response to neoadjuvant chemotherapy[J]. Eur J Nucl Med Mol Imaging, 2019, 46: 1468-1477. DOI: 10.1007/s00259-019-04313-8
    [33]
    Braman NM, Etesami M, Prasanna P, et al. Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI[J]. Breast Cancer Res, 2017, 19: 57. DOI: 10.1186/s13058-017-0846-1
    [34]
    Sutton EJ, Onishi N, Fehr DA, et al. A machine learning model that classifies breast cancer pathologic complete response on MRI post-neoadjuvant chemotherapy[J]. Breast Cancer Res, 2020, 22: 57. DOI: 10.1186/s13058-020-01291-w
    [35]
    Bitencourt AGV, Gibbs P, Rossi Saccarelli C, et al. MRI-based machine learning radiomics can predict HER2 expression level and pathologic response after neoadjuvant therapy in HER2 overexpressing breast cancer[J]. EBioMedicine, 2020, 61: 103042. DOI: 10.1016/j.ebiom.2020.103042
    [36]
    Moscoso A, Ruibal A, Dominguez-Prado I, et al. Texture analysis of high-resolution dedicated breast (18) F-FDG PET images correlates with immunohistochemical factors and subtype of breast cancer[J]. Eur J Nucl Med Mol Imaging, 2018, 45: 196-206. DOI: 10.1007/s00259-017-3830-1
    [37]
    Antunovic L, Gallivanone F, Sollini M, et al. [(18)F]FDG PET/CT features for the molecular characterization of primary breast tumors[J]. Eur J Nucl Med Mol Imaging, 2017, 44: 1945-1954. DOI: 10.1007/s00259-017-3770-9
    [38]
    Fan M, Yuan W, Zhao W, et al. Joint Prediction of Breast Cancer Histological Grade and Ki-67 Expression Level Based on DCE-MRI and DWI Radiomics[J]. IEEE J Biomed Health Inform, 2020, 24: 1632-1642. DOI: 10.1109/JBHI.2019.2956351
    [39]
    Yang X, Wu L, Zhao K, et al. Evaluation of human epidermal growth factor receptor 2 status of breast cancer using preoperative multidetector computed tomography with deep learning and handcrafted radiomics features[J]. Chin J Cancer Res, 2020, 32: 175-185. DOI: 10.21147/j.issn.1000-9604.2020.02.05
    [40]
    Leithner D, Bernard-Davila B, Martinez DF, et al. Radiomic Signatures Derived from Diffusion-Weighted Imaging for the Assessment of Breast Cancer Receptor Status and Molecular Subtypes[J]. Mol Imaging Biol, 2020, 22: 453-461. DOI: 10.1007/s11307-019-01383-w
    [41]
    Parekh VS, Jacobs MA. Multiparametric radiomics methods for breast cancer tissue characterization using radiological imaging[J]. Breast Cancer Res Treat, 2020, 180: 407-421. DOI: 10.1007/s10549-020-05533-5
    [42]
    Leithner D, Mayerhoefer ME, Martinez DF, et al. Non-Invasive Assessment of Breast Cancer Molecular Subtypes with Multiparametric Magnetic Resonance Imaging Radiomics[J]. J Clin Med, 2020, 9: 1853. DOI: 10.3390/jcm9061853
    [43]
    Xie T, Wang Z, Zhao Q, et al. Machine Learning-Based Analysis of MR Multiparametric Radiomics for the Subtype Classification of Breast Cancer[J]. Front Oncol, 2019, 9: 505. DOI: 10.3389/fonc.2019.00505
    [44]
    Huang SY, Franc BL, Harnish RJ, et al. Exploration of PET and MRI radiomic features for decoding breast cancer phenotypes and prognosis[J]. NPJ Breast Cancer, 2018, 4: 24. DOI: 10.1038/s41523-018-0078-2
    [45]
    Park H, Lim Y, Ko ES, et al. Radiomics Signature on Magnetic Resonance Imaging: Association with Disease-Free Survival in Patients with Invasive Breast Cancer[J]. Clin Cancer Res, 2018, 24: 4705-4714. DOI: 10.1158/1078-0432.CCR-17-3783
    [46]
    Kim S, Kim MJ, Kim EK, et al. MRI Radiomic Features: Association with Disease-Free Survival in Patients with Triple-Negative Breast Cancer[J]. Sci Rep, 2020, 10: 3750. DOI: 10.1038/s41598-020-60822-9
    [47]
    Koh J, Lee E, Han K, et al. Three-dimensional radiomics of triple-negative breast cancer: Prediction of systemic recurrence[J]. Sci Rep, 2020, 10: 2976. DOI: 10.1038/s41598-020-59923-2
    • Related Articles

  • Related Articles

    [1]YAN Xinchun, HUO Li. Evaluation of Von Hippel-Lindau Syndrome Through Novel Small Molecular Tracer 68Ga-NY104 PET/CT Imaging[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(4): 911-915. DOI: 10.12290/xhyxzz.2024-0216
    [2]ZHANG Yao, ZHAO Chengjun, REN Bin, DU Lei, MA Qianyuan. Research Progress on Prognostic Prediction Models After Radical Resection of Hepatocellular Carcinoma[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(6): 1266-1273. DOI: 10.12290/xhyxzz.2023-0235
    [3]LIU Huan, HUANG Xiaoling, DAI Mengying, GUO Jiejie, GAO feng. Clinical Characteristics and Inflammatory Markers of Omicron BA.5.2 Variant Infection in Hospitalized Patients and Their Predictive Role in Disease Prognosis[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(5): 1038-1045. DOI: 10.12290/xhyxzz.2023-0055
    [4]YANG Wenlei, LIU Fangfang, XU Ruiping, YANG Wei, HE Yu, LIU Zhen, ZHOU Fuyou, HENG Fanxiu, HOU Bolin, ZHANG Lixin, CHEN Lei, ZHANG Fan, CAI Fen, XU Huawen, LIN Miaoping, LIU Mengfei, PAN Yaqi, LIU Ying, HU Zhe, CHEN Huanyu, HE Zhonghu, KE Yang. Development and Validation of A Prognosis Prediction Model for Esophageal Squamous Cell Carcinoma Patients Treated with Esophagectomy: A Multicenter Real-world Cohort Study[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(1): 101-113. DOI: 10.12290/xhyxzz.2022-0496
    [5]Rare Diseases Society of Chinese Research Hospital Association, National Rare Diseases Committee, Beijing Rare Disease Diagnosis, Treatment and Protection Society, Gitelman Syndrome Consensus Working Group. Expert Consensus for the Diagnosis and Treatment of Gitelman Syndrome in China (2021)[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(6): 902-912. DOI: 10.12290/xhyxzz.2021-0555
    [6]ZHANG Gumuyang, XU Lili, MAO Li, LI Xiuli, JIN Zhengyu, SUN Hao. CT-based Radiomics to Predict Recurrence of Bladder Cancer after Resection in One Year: A Preliminary Study[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(5): 698-704. DOI: 10.12290/xhyxzz.2021-0511
    [7]Yan-meng QI, Ye-cheng LIU, Hua-dong ZHU. Predictive Value of Ranson Score for Typing Moderately Severe and Severe Hyperlipidemic Acute Pancreatitis[J]. Medical Journal of Peking Union Medical College Hospital, 2019, 10(5): 489-493. DOI: 10.3969/j.issn.1674-9081.2019.05.011
    [8]Jia-qi ZHANG, Lei LIU, Gui-ge WANG, Wen-liang BAI, Shan-qing LI. Clinical Pathological Features and Prognosis of Non-small Cell Lung Cancer with Skip N2 Lymph Node Metastasis[J]. Medical Journal of Peking Union Medical College Hospital, 2019, 10(3): 272-277. DOI: 10.3969/j.issn.1674-9081.2019.03.015
    [9]Qing-yuan DENG, Yi-cong YE, Ying ZHONG, Miao-miao SHENG, Feng-ming HUANG, Cheng-yu JIANG, Shu-yang ZHANG. Angiotensin Ⅱ in Predicting the In-hospital Prognosis of Patients Undergoing Elective Percutaneous Coronary Intervention[J]. Medical Journal of Peking Union Medical College Hospital, 2016, 7(1): 13-17. DOI: 10.3969/j.issn.1674-9081.2016.01.003
    [10]Shuai TANG, Jie YI, Yu-guang HUANG. Cardiovascular Responses of Intubation with Shikani Seeing Optical Stylet and Macintosh Laryngoscope[J]. Medical Journal of Peking Union Medical College Hospital, 2012, 3(3): 314-317. DOI: 10.3969/j.issn.1674-9081.2012.03.015

  • Cited by

    Periodical cited type(6)

    1. 曹婷婷，丁雪委，郑皓，葛敏，王世威. 预测浸润性乳腺癌无病生存期的临床影像融合模型研究. 浙江医学. 2024(02): 156-161 .
    2. 李昊，侯岩，殷小平. 基于MRI影像组学在乳腺癌分子分型的研究进展. 医学研究与教育. 2024(02): 21-28 .
    3. 米拉·也尔兰，张海见，胡峙珩，冷晓玲. 超声影像组学对BI-RADS 4a类不规则乳腺结节良恶性的鉴别价值. 分子影像学杂志. 2023(01): 12-20 .
    4. 李雪儿，王正业，买买提吐逊·吐尔地. 基于影像组学鉴定头颈部鳞状细胞癌患者HPV状态：诊断性meta分析. 中国口腔颌面外科杂志. 2023(01): 69-74 .
    5. 李影，邱丽华. 宫颈癌MRI影像组学研究现状及进展. 中国医学影像技术. 2023(09): 1407-1410 .
    6. 刘静宇，刘颖，张帆. 影像组学的临床应用研究及挑战. 山西大同大学学报(自然科学版). 2022(04): 67-72 .

    Other cited types(6)

Catalog

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (1069) PDF downloads (215) Cited by(12)
    Related
    Links: National Health Commission of the People's Republic of China Chinese Academy of Medical Sciences(CAMS) AMLC Check CNKI Database CNKI Term Online Chinese General Practice
    Address：Room 302,Third Floor,Building 7, No. 1 Shuaifuyuan, Wangfujing, Dongcheng District, Beijing 100730, China
    Tel：010-69154261/4262
    E - mail：medj@pumch.cn mjpumch@126.com
    Copyright of website：Editorial Office of Medical Journal of Peking Union Medical College Hospital

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return
    x Close Forever Close